Amesite shares surge 18.94% after-hours after launching AI-native NurseMagic EMR, following strong revenue growth from product tiers.

Amesite Inc. surged 18.94% in after-hours trading following the launch of its AI-native NurseMagic™ EMR, expanding its platform into core post-acute care infrastructure. The announcement highlighted a modular system compatible with legacy systems or full replacement, positioning the company to target a $470 billion U.S. post-acute care market projected to exceed $850 billion. Sequential revenue growth accelerated after product tier introductions, including a 2.4x increase post-Teams+ launch in May 2025, an 82% Q4 rise after the July 2025 Enterprise tier, and a 69% Q1 fiscal 2026 increase. CEO Ann Marie Sastry emphasized the EMR’s alignment with patient-volume-based pricing and infrastructure-level adoption, while website traffic rose 1,400% since January 2025, underscoring growing demand for AI-driven healthcare solutions. The launch reinforces Amesite’s competitive edge in a rapidly expanding sector, aligning with McKinsey’s estimate of $2.6–$4.4 trillion in annual value from AI integration into core systems.